Nature Medicine

Nature Medicine is an academic journal publishing research articles, reviews, news and commentaries in the biomedical area, including both basic research and early-phase clinical research. Topics covered include cancer, cardiovascular disease, gene therapy, immunology, vaccines, and neuroscience. The journal seeks to publish research papers that demonstrate novel insight into disease processes, with direct evidence of the physiological relevance of the results. Founded in 1995, Nature Medicine is published by the Nature Publishing Group, a division of Macmillan Publishers Ltd, and is one of the rapidly expanding stable of Nature journals. As with other Nature journals, there is no external Editorial Board, with editorial decisions being made by an in-house team, although peer review by external expert referees forms a part of the review process. Nature Medicine is published monthly. Articles are archived online in text and PDF formats; access is by subscription only. Its 2010 impact factor was 25.430, making it the highest-cited research journal in preclinical medicine. It is also among the highest impact of primary (non-review) scientific journals.

Publisher
Nature Publishing Group
History
1995--present
Impact factor
25.430 (2010)

Some content from Wikipedia, licensed under CC BY-SA

Immunology

Protective antibodies also found in premature babies

Even premature babies carry anti-viral antibodies transferred from the mother, researchers at Karolinska Institutet in Sweden report in a paper on maternal antibodies in newborns, published in the journal Nature Medicine. ...

Immunology

Researchers report metric of immune system's biological clock

A new study published in Nature Medicine from scientists at the Technion, Stanford and CytoReason describes for the first time ever a way to quantify a person's "immune age." This game-changing capability provides a much ...

Cancer

Promising new pancreatic cancer treatment moves forward

Even among cancers, pancreatic cancer is an especially sinister form of disease. The one-year survival rate is extremely low, and treatment progress has lagged behind that of many other malignancies.

Cancer

New strategy to tackle 'don't eat me' signal on cancer cells

Myeloid immune cells kill cancer cells by eating them but cancer cells prevent this from happening by giving out a 'do not eat me' signal. Led by immunologists Ton Schumacher (Netherlands Cancer Institute and Oncode) and ...

Cancer

Potential treatment strategy uncovered for pancreatic cancer

Scientists at the University of North Carolina Lineberger Comprehensive Cancer Center discovered a technique to make pancreatic cancer cells reliant on one energy source and then starve them of it—a finding that has led ...

Neuroscience

Thought-controlled computer cursor takes a leap forward

Scientists working to perfect a thought-controlled computer cursor said Monday they have achieved their best results yet, and are moving closer to creating a version that paralysis victims can use.

Medical research

A new CRISPR/Cas9 therapy can suppress aging

Aging is a leading risk factor for a number of debilitating conditions, including heart disease, cancer and Alzheimer's disease, to name a few. This makes the need for anti-aging therapies all the more urgent. Now, Salk Institute ...

page 1 from 50